Search
Close
Search
Advanced Search
Search Menu
AI Discovery Assistant

Pandey, J. P., J. Olsson, B. Weidung, R. T. Kothera, A. Johansson, S. Eriksson, G. Hallmans, F. Elgh, and H. Lövheim. 2020. An Ig γ marker genotype is a strong risk factor for Alzheimer disease, independent of apolipoprotein E ε4 genotype. J. Immunol. 205: 1318–1322.

The footnotes for Table III were omitted from the article as originally published. Table III is shown below with the footnotes included. The table has also been corrected in the online article, which now differs from the article as originally published.

Table III.
Open in new tab

Baseline characteristics among GM 17/17 carriers and noncarriers

GM 17/17 CarriersGM 17/17 Noncarriersp
Age, mean ± SD (n)61.4 ± 5.1 (111)61.1 ± 5.7 (617)0.645
Male sex, n (%)27 (24.3)157 (25.4)0.802
Anti-HSV1 IgG carriership, n (%)100 (90.9)541 (89.3)0.606
Anti-HSV IgG level, AU, mean ± SD (n)a95.4 ± 26.5 (100)104.0 ± 20.4 (541)0.003
Anti-HSV IgM carriership, n (%)6 (5.5)41 (6.8)0.609
APOE risk-variant carriershipb, n (%)44 (41.1)258 (43.9)0.597
GM 17/17 CarriersGM 17/17 Noncarriersp
Age, mean ± SD (n)61.4 ± 5.1 (111)61.1 ± 5.7 (617)0.645
Male sex, n (%)27 (24.3)157 (25.4)0.802
Anti-HSV1 IgG carriership, n (%)100 (90.9)541 (89.3)0.606
Anti-HSV IgG level, AU, mean ± SD (n)a95.4 ± 26.5 (100)104.0 ± 20.4 (541)0.003
Anti-HSV IgM carriership, n (%)6 (5.5)41 (6.8)0.609
APOE risk-variant carriershipb, n (%)44 (41.1)258 (43.9)0.597
a

Tested among anti-HSV1 IgG carriers, of which some may also be anti-HSV2 IgG carriers.

b

APOE ε3/ε4 or APOE ε4/ε4.

Table III.
Open in new tab

Baseline characteristics among GM 17/17 carriers and noncarriers

GM 17/17 CarriersGM 17/17 Noncarriersp
Age, mean ± SD (n)61.4 ± 5.1 (111)61.1 ± 5.7 (617)0.645
Male sex, n (%)27 (24.3)157 (25.4)0.802
Anti-HSV1 IgG carriership, n (%)100 (90.9)541 (89.3)0.606
Anti-HSV IgG level, AU, mean ± SD (n)a95.4 ± 26.5 (100)104.0 ± 20.4 (541)0.003
Anti-HSV IgM carriership, n (%)6 (5.5)41 (6.8)0.609
APOE risk-variant carriershipb, n (%)44 (41.1)258 (43.9)0.597
GM 17/17 CarriersGM 17/17 Noncarriersp
Age, mean ± SD (n)61.4 ± 5.1 (111)61.1 ± 5.7 (617)0.645
Male sex, n (%)27 (24.3)157 (25.4)0.802
Anti-HSV1 IgG carriership, n (%)100 (90.9)541 (89.3)0.606
Anti-HSV IgG level, AU, mean ± SD (n)a95.4 ± 26.5 (100)104.0 ± 20.4 (541)0.003
Anti-HSV IgM carriership, n (%)6 (5.5)41 (6.8)0.609
APOE risk-variant carriershipb, n (%)44 (41.1)258 (43.9)0.597
a

Tested among anti-HSV1 IgG carriers, of which some may also be anti-HSV2 IgG carriers.

b

APOE ε3/ε4 or APOE ε4/ε4.

Copyright © 2020 by The American Association of Immunologists, Inc.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/pages/standard-publication-reuse-rights)
Issue Section:
Corrections
Download all slides